På grund af den potentielle sensivitet af hurtigt delende myeloide celler over for cytotoksisk kemoterapi, bør Neulasta administreres cirka 24 timer efter cytotoksisk kemoterapi.
Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ Neulasta should be administered approximately 24 hours after administration of cytotoxic chemotherapy.